Innovative development path of ethnomedicines: a case study

Zhu, Zhaoyun; Gui, Yali; Wang, Li; Wang, Ting; Yang, Yang; Niu, Yunzhuang; Fu, Dehuan; Wang, Jingkun; Cui, Tingwei

doi:10.1007/s11684-017-0513-z

Cited by 8 publications

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Apart from direct contribution in local communities, traditional medicine has been utilized for new drug discovery by modern scientific techniques and methods [ 5 ]. Not only people worldwide could benefit from the research and development (R&D) of traditional medicine products, but also LMICs could consider the industrialization of traditional medicine products as an economic growth point and a sign of influence [ 6 ].…”

Section: Introductionmentioning

confidence: 99%

Drug research and development opportunities in low- and middle-income countries: accelerating traditional medicine through systematic utilization and comprehensive synergy

et al. 2022

View full text Add to dashboard Cite

Background Though the utilization of traditional medicine has been proposed for modern drug research and development (R&D), limited research has discussed its feasible paths. In this commentary, we summarized key factors for new drug R&D under limited resources by reviewing China’s discovery of artemisinin, and raised suggestions to utilize traditional medicines in low- and middle-income countries (LMICs). Main text We suggested that systematic utilization of traditional medicine, outstanding synergy of research units at all levels and timely information-sharing mechanism should be achieved to establish a comprehensive and efficient R&D system, especially under low-resource settings. In the case of artemisinin discovery, Chinese scientists integrated documented traditional medicine experiences and modern approaches to develop drug candidates timely. Due to limited R&D resources, China adopted a collaborative way, motivating nearly all domestic research units at different levels, to develop antimalarial products. Moreover, the excellent synergy among all units through efficient information-sharing mechanisms greatly avoided work repetition and accelerated the R&D process. Conclusion Traditional medicines inspires drug discoveries in LMICs, while a comprehensive and efficient R&D system could accelerate its R&D process and save investment. The discovery of artemisinin in China gave a reliable pattern to promote sustainable development of traditional medicines and a good example to realize R&D of traditional medicine under low-resource settings.

show abstract

Section: Introductionmentioning

confidence: 99%